Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait

Background. Multiple sclerosis (MS) therapeutics entered a new era after the development of anti-JC virus (anti-JCV) antibody assay that assesses the risk of development of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab. Objective. To determine the prevalence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamdhade, S., Ashkanani, A., Alroughani, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920602/
https://www.ncbi.nlm.nih.gov/pubmed/24587917
http://dx.doi.org/10.1155/2014/861091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920602/
https://www.ncbi.nlm.nih.gov/pubmed/24587917
http://dx.doi.org/10.1155/2014/861091

Ejemplares similares